Linda Pescatello, Board of Trustees Distinguished Professor in the Department of Kinesiology (CAHNR), has established herself ...
A 62-year-old Bengaluru resident, Sanjay Kumar Gupta, experienced a remarkable 90% improvement in mobility and daily function ...
Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...
The FDA has approved Exdensur for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in patients aged 12 and older.
Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two ...
Zacks Investment Research on MSN
GSK's Exdensur gets FDA nod for severe asthma treatment
GSK plc GSK announced that the FDA has approved Exdensur (depemokimab-ulaa), an ultra-long-acting IL-5–targeting biologic, as ...
The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...
The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.
St. Elizabeth Healthcare If you have asthma, you know you face unique challenges in winter. The good news is you can take ...
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment of severe asthma characterised by an ...
An experimental new medication claims to help people lose weight without muscle loss. Here’s what you need to know about the ...
Personal narratives on allergy and asthma conditions which contained inaccuracies gained the most traction online.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback